Human Sperm Bank, West China Second University Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.
Department of Andrology, West China Second University Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.
Reprod Sci. 2024 Feb;31(2):366-374. doi: 10.1007/s43032-023-01362-1. Epub 2023 Sep 25.
Patients with Idiopathic non-obstructive azoospermia (iNOA) can achieve fertility by extracting testicular sperm through microdissection testicular sperm extraction (mTESE). But more than half of iNOA patients still cannot benefit from mTESE. In recent years, some studies had reported that serum hormones may be related to the outcome of sperm retrieval, but few had been verified. We hope to obtain a predictive method that is convenient for clinical application and can help judge the outcome of sperm extraction before implementing mTESE. We performed a retrospective analysis of NOA patients who underwent mTESE in the same andrology center from June 2020 to November 2022. A total of 261 patients with complete data were collected, logistic regression analysis was performed and a predictive model was constructed. Then, from December 2022 to May 2023, one prospective cohort of 48 NOA patients who met the inclusion criteria from the same center was recruited to validate the risk prediction model. We successfully constructed a logistic regression model to predict the outcome of iNOA patients undergoing mTESE and found that higher serum anti-Müllerian hormone (AMH) levels were associated with failure sperm retrieval, resulting in an AMH cut-off of 2.60 ng/ml. The area under the receiver operating curve was 0.811, the sensitivity was 0.870, and the specificity was 0.705. Decision curve analysis demonstrated that the threshold probability was above 4%, and unnecessary mTESE could be reduced using this model. In a prospective cohort at the same center, 85.42% (41/48) of iNOA patients correctly identified the mTESE outcome using this model. A logistic regression model with AMH as an independent predictor can predict mTESE outcomes in iNOA patients. Preoperative selection of mTESE in patients with iNOA using this model had clinical benefit in reducing unnecessary surgery. The model demonstrated good accuracy in a small prospective cohort validation.
特发性非梗阻性无精子症(iNOA)患者可通过经微切割睾丸精子提取术(mTESE)提取睾丸精子实现生育。但仍有超过一半的 iNOA 患者无法从 mTESE 中受益。近年来,一些研究报告称血清激素可能与精子提取的结果有关,但很少有研究得到验证。我们希望获得一种方便临床应用的预测方法,以便在实施 mTESE 前帮助判断精子提取的结果。我们对 2020 年 6 月至 2022 年 11 月在同一男科中心接受 mTESE 的 NOA 患者进行了回顾性分析。共收集了 261 例数据完整的患者,进行了逻辑回归分析并构建了预测模型。然后,从 2022 年 12 月至 2023 年 5 月,从同一中心招募了 48 例符合纳入标准的前瞻性队列 NOA 患者,以验证风险预测模型。我们成功构建了预测 iNOA 患者 mTESE 结果的逻辑回归模型,发现较高的血清抗苗勒管激素(AMH)水平与精子提取失败相关,导致 AMH 截断值为 2.60ng/ml。受试者工作特征曲线下面积为 0.811,灵敏度为 0.870,特异性为 0.705。决策曲线分析表明,阈值概率超过 4%,使用该模型可以减少不必要的 mTESE。在同一中心的前瞻性队列中,85.42%(41/48)的 iNOA 患者使用该模型正确识别了 mTESE 的结果。以 AMH 为独立预测因子的逻辑回归模型可以预测 iNOA 患者 mTESE 的结果。在 iNOA 患者中使用该模型选择 mTESE 具有减少不必要手术的临床益处。该模型在小的前瞻性队列验证中具有良好的准确性。